The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The inhibition of CCR2 to modify the microenvironment in pancreatic cancer mouse model and to support the profiling of the CCR2 inhibitor CCX872-B in patients.
 
Andrea Wang-Gillam
Honoraria - Merrimack; Pfizer
Consulting or Advisory Role - Merrimack; pfizer
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); CTI (Inst); EMD Serono (Inst); Halozyme (Inst); Merrimack (Inst); Newlink Genetics (Inst); OncoMed (Inst); pfizer (Inst); Precision Therapeutics (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Axis Pharma
 
Marcus Smith Noel
Consulting or Advisory Role - Dava Oncology; Taiho Pharmaceutical
 
Stefan Sleijfer
No Relationships to Disclose
 
Heiyoun Jung
Employment - ChemoCentryx
 
Lisa Lohr
Employment - ChemoCentryx
 
Niky Zhao
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Shichang Miao
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Antonia Potarca
Employment - ChemoCentryx
 
Israel Charo
Employment - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
 
Petrus Bekker
Employment - ChemoCentryx
Leadership - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Patents, Royalties, Other Intellectual Property - ChemoCentryx
 
Thomas J. Schall
Employment - ChemoCentryx
Leadership - ChemoCentryx
Stock and Other Ownership Interests - ChemoCentryx
Patents, Royalties, Other Intellectual Property - ChemoCentryx